DAYTRANA Side Effects

7004738-1 | Application Site Erythema, Application Site Pruritus, Crying, Depressed Mood, Emotional Disorder, Hernia, Insomnia, Product Quality Issue, Psychomotor Hyperactivity
on Sep 08, 2010 Female patient from UNITED STATES , weighting 63.71 lb, was diagnosed with attention deficit/hyperactivity disorder, asthma (What is asthma?) and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, application site pruritus, crying, depressed mood, emotional disorder, hernia (What is hernia?), insomnia, product quality issue, psychomotor hyperactivity. Daytrana dosage: 10 Mg, 1x/day:qd.

6977897-4 | Application Site Rash, Back Pain, Blood Pressure Increased, Dyspnoea, Feeling Abnormal, Headache, Hypersensitivity, Hypoaesthesia, Loss Of Consciousness
Patient was taking Daytrana (View Usage). Patient had the following side effects: application site rash, back pain (What is back pain?), blood pressure increased, dyspnoea, feeling abnormal, headache (What is headache?), hypersensitivity, hypoaesthesia, loss of consciousness on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 104.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 20 Mg, 1x/day:qd.

6866707-1 | Aggression, Decreased Appetite, Weight Decreased
Adverse event was reported on Feb 08, 2010 by a Female patient taking Daytrana (View Usage) (Dosage: 10 Mg, 1/xday:qd, Transdermal ; 10 Mg, 1x/day:qd, Transdermal ; 10 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 8 years of age, weighting 67.90 lb, After Daytrana was administered, patient had the following side effects: aggression, decreased appetite, weight decreased. Patient was hospitalized.

6785218-5 | Abdominal Pain Upper, Chest Pain
on Jun 22, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, chest pain (What is chest pain?). Daytrana dosage: . Patient was hospitalized.


6745636-8 | Product Quality Issue
on May 26, 2010 Male patient from UNITED STATES , weighting 50.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: product quality issue. Daytrana dosage: 1 Patch Daily Cutaneous.

6743587-6 | Hypersensitivity
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: hypersensitivity on May 26, 2010 from UNITED STATES Additional patient health information: Female patient , child 5 years of age, weighting 50.00 lb, . Daytrana dosage: 10mg Apply Daily Patch.

6717714-0 | Application Site Discolouration, Application Site Erythema, Application Site Pain, Application Site Pruritus, Application Site Swelling, Nephrolithiasis, Off Label Use, Product Adhesion Issue, Product Quality Issue
Adverse event was reported on Apr 21, 2010 by a Male patient taking Daytrana (View Usage) (Dosage: 15mg, 1x/day Qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 29 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: application site discolouration, application site erythema, application site pain, application site pruritus, application site swelling, nephrolithiasis, off label use, product adhesion issue, product quality issue. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), XOPENEX (LEVOSALBUTAMOL) INHALATION GAS (View Xopenex (levosalbutamol) Inhalation Gas Review and Xopenex (levosalbutamol) Inhalation Gas Label ). Patient was hospitalized.

6609203-9 | Appendicitis, Application Site Dermatitis, Dermatitis Contact, Off Label Use, Product Adhesion Issue, Product Quality Issue
on Feb 16, 2010 Male patient from UNITED STATES , child 5 years of age, weighting 39.02 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: appendicitis (What is appendicitis?), application site dermatitis, dermatitis contact, off label use, product adhesion issue, product quality issue. Daytrana dosage: 10 Mg, 1 X/day: Qd, Transdermal. Patient was hospitalized.

6608642-X | Application Site Haematoma, Pneumonia
on Feb 17, 2010 Male patient from UNITED STATES , child 9 years of age, weighting 65.04 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site haematoma, pneumonia (What is pneumonia?). Daytrana dosage: 30 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with METHYLIN (METHYLPHENIDATE HYDROCHLORIDE) TABLET (View Methylin (methylphenidate Hydrochloride) Tablet Review and Methylin (methylphenidate Hydrochloride) Tablet Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), CLONIDINE (CLONIDINE) TABLET (View Clonidine (clonidine) Tablet Review and Clonidine (clonidine) Tablet Label ), MELATONIN (MELATONIN) TABLET (View Melatonin (melatonin) Tablet Review and Melatonin (melatonin) Tablet Label ), RITALIN (View Ritalin Review and Ritalin Label ).

6567460-1 | Cerebrovascular Accident, Epilepsy, Fibromuscular Dysplasia, Sinusitis, Somnolence, Staring
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, epilepsy (What is epilepsy?), fibromuscular dysplasia, sinusitis (What is sinusitis?), somnolence, staring on Jan 13, 2010 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, weighting 53.57 lb, . Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal. Patient was hospitalized.

6553466-5 | Abnormal Behaviour, Off Label Use
Adverse event was reported on Jan 20, 2010 by a Female patient taking Daytrana (View Usage) (Dosage: 10 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 17 years of age, Patient had the following side effects: abnormal behaviour, off label use. Patient was hospitalized.

6539874-7 | Appendicitis, Off Label Use, Product Adhesion Issue, Product Quality Issue
on Jan 02, 2010 Male patient from UNITED STATES , child 5 years of age, weighting 39.02 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: appendicitis (What is appendicitis?), off label use, product adhesion issue, product quality issue. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal. Patient was hospitalized.

6539856-5 | Abnormal Behaviour, Blood Creatine Phosphokinase Increased, Off Label Use
on Jan 04, 2010 Female patient from UNITED STATES , 17 years of age, was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, blood creatine phosphokinase increased, off label use. Daytrana dosage: . Patient was hospitalized.

6531525-0 | Decreased Appetite, Fluid Intake Reduced, Weight Increased
Patient was taking Daytrana (View Usage). Patient had the following side effects: decreased appetite, fluid intake reduced, weight increased on Oct 13, 2009 from UNITED STATES Additional patient health information: Female patient , child 6 years of age, weighting 50.04 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal ; 15 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with VYVANSE (20 Mg, 1x/day:qd, Oral) (View Vyvanse Review and Vyvanse Label ).

6530059-7 | Abdominal Pain Lower, Appendicitis, Calcinosis, Faecalith
Adverse event was reported on Dec 29, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 20 Mg, 1x/ Day:qd, Transdermal; 30 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 9 years of age, weighting 59.08 lb, After Daytrana was administered, patient had the following side effects: abdominal pain lower, appendicitis (What is appendicitis?), calcinosis, faecalith. During the same period patient was treated with CELEXA /00582602/ (CITALOPRAM HYDROBROMIDE) TABLET (View Celexa /00582602/ (citalopram Hydrobromide) Tablet Review and Celexa /00582602/ (citalopram Hydrobromide) Tablet Label ), VITAMINS /00067501/ (ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETI (View Vitamins /00067501/ (ascorbic Acid, Ergocalciferol, Nicotinamide, Reti Review and Vitamins /00067501/ (ascorbic Acid, Ergocalciferol, Nicotinamide, Reti Label ). Patient was hospitalized.

6523072-7 | Crying, Depressed Mood, Self Injurious Behaviour, Suicidal Ideation
on Dec 08, 2009 Male patient from UNITED STATES , child 11 years of age, weighting 85.98 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: crying, depressed mood, self injurious behaviour, suicidal ideation. Daytrana dosage: 10 Mg, 1x/day:day, Transdermal; 20 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6522114-2 | Application Site Haematoma, Pneumonia
on Dec 16, 2009 Male patient from UNITED STATES , child 9 years of age, weighting 65.04 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: application site haematoma, pneumonia (What is pneumonia?). Daytrana dosage: 30 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with METHYLIN (METHYLPHENIDATE HYDROCHLORIDE) (View Methylin (methylphenidate Hydrochloride) Review and Methylin (methylphenidate Hydrochloride) Label ), MITAZAPINE (MIRTAZAPINE) (View Mitazapine (mirtazapine) Review and Mitazapine (mirtazapine) Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), MELATONIN (MELATONIN) (View Melatonin (melatonin) Review and Melatonin (melatonin) Label ).

6492651-8 | Appendicitis
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: appendicitis (What is appendicitis?) on Nov 24, 2009 from UNITED STATES Additional patient health information: Male patient , child 9 years of age, weighting 59.08 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal, 30 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), VITAMINS (ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFL (View Vitamins (ascorbic Acid, Ergocalciferol, Nicotinamide, Retinol, Ribofl Review and Vitamins (ascorbic Acid, Ergocalciferol, Nicotinamide, Retinol, Ribofl Label ). Patient was hospitalized.

6492634-8 | Pregnancy, Spinal Fusion Surgery, Therapeutic Response Unexpected
Adverse event was reported on Dec 02, 2009 by a Female patient taking Daytrana (View Usage) (Dosage: 30 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 37 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?), spinal fusion surgery, therapeutic response unexpected. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), AMBIEN (View Ambien Review and Ambien Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6483493-8 | Depression, Scratch, Suicidal Ideation
on Dec 08, 2009 Male patient from UNITED STATES , weighting 86.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: depression (What is depression?), scratch, suicidal ideation. Daytrana dosage: 1 20 Mg Patch Daily Transdermal. During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ).

6456616-4 | Abnormal Behaviour, Activities Of Daily Living Impaired, Aggression, Bite, Enuresis, Incorrect Dose Administered, Insomnia, Mental Status Changes
on Nov 04, 2009 Male patient from UNITED STATES , 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: abnormal behaviour, activities of daily living impaired, aggression, bite, enuresis, incorrect dose administered, insomnia, mental status changes. Daytrana dosage: 1x/day:qd, Transdermal, 1x/day:qd 1/2 Patch Daily, Transdermal. During the same period patient was treated with NATURAL SUPPLEMENTS (View Natural Supplements Review and Natural Supplements Label ). Patient was hospitalized.

6441237-X | Decreased Appetite, Depression, Insomnia, Suicidal Ideation
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, depression (What is depression?), insomnia, suicidal ideation on Oct 29, 2009 from UNITED STATES Additional patient health information: Male patient , child 10 years of age, weighting 69.89 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 30 Mg, 1x/day;qd, 30 Mg, 1x/day:qd, Transdermal.

6432228-3 | Off Label Use, Pregnancy, Spinal Fusion Surgery, Therapeutic Response Unexpected
Adverse event was reported on Oct 23, 2009 by a Female patient taking Daytrana (View Usage) (Dosage: 30 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 37 years of age, weighting 130.1 lb, Patient had the following side effects: off label use, pregnancy (What is pregnancy?), spinal fusion surgery, therapeutic response unexpected. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

6417456-5 | Dyskinesia, Oedema Mouth, Paraesthesia Oral, Swollen Tongue
on Oct 27, 2009 Male patient from UNITED STATES , weighting 36.00 lb, was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: dyskinesia, oedema mouth, paraesthesia oral, swollen tongue. Daytrana dosage: 10mg Once In Am Transdermal.

6414600-0 | Confusional State, Disorientation, Headache, Incoherent, Neurological Examination Abnormal, Vomiting
on Oct 12, 2009 Female patient from UNITED STATES , child 10 years of age, weighting 97.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disorientation, headache (What is headache?), incoherent, neurological examination abnormal, vomiting. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6407860-3 | Blood Pressure Increased, Disorientation, Dizziness, Dysarthria, Eye Rolling, Hypersensitivity, Muscle Rigidity, Nervousness, Off Label Use
Patient was taking Daytrana (View Usage). Patient had the following side effects: blood pressure increased, disorientation, dizziness (What is dizziness?), dysarthria, eye rolling, hypersensitivity, muscle rigidity, nervousness, off label use on Oct 06, 2009 from UNITED STATES Additional patient health information: Male patient , 13 years of age, weighting 97.22 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 10 Mg, One Dose, Transdermal.

6387448-3 | Blood Pressure Increased, Disorientation, Eye Rolling, Feeling Jittery, Nervousness, Off Label Use, Pallor, Product Quality Issue, Pupil Fixed
Adverse event was reported on Sep 18, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 10 Mg, One Dose, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 13 years of age, weighting 97.00 lb, After Daytrana was administered, patient had the following side effects: blood pressure increased, disorientation, eye rolling, feeling jittery, nervousness, off label use, pallor, product quality issue, pupil fixed.

6381417-5 | Product Quality Issue, Visual Impairment
on Sep 16, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 41.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue, visual impairment. Daytrana dosage: 15 Mg, 1 X/day:qd, Transdermal. During the same period patient was treated with PROZAC /00724401/ (FLUOXETINE) TABLET (View Prozac /00724401/ (fluoxetine) Tablet Review and Prozac /00724401/ (fluoxetine) Tablet Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).

6378888-7 | Dehydration, Off Label Use, Orthostatic Hypotension, Syncope, Tachycardia
on Sep 14, 2009 Female patient from UNITED STATES , 14 years of age, was treated with Daytrana (View Usage). Patient had the following side effects: dehydration, off label use, orthostatic hypotension, syncope, tachycardia. Daytrana dosage: 1x/day:qd, Transdermal.

6378842-5 | Application Site Erythema, Application Site Pain, Application Site Pruritus, Dizziness, Feeling Abnormal, Lyme Disease, Medical Device Site Reaction, Off Label Use
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site erythema, application site pain, application site pruritus, dizziness (What is dizziness?), feeling abnormal, lyme disease, medical device site reaction, off label use on Sep 16, 2009 from UNITED STATES Additional patient health information: Male patient , child 5 years of age, weighting 41.89 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 15 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ), VITAMINS NOS (VITAMINS NOS) (View Vitamins Nos (vitamins Nos) Review and Vitamins Nos (vitamins Nos) Label ). Patient was hospitalized.

6376459-X | Condition Aggravated, Tic
Adverse event was reported on Sep 22, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 15 Mg Qd Cutaneous) was diagnosed with attention deficit/hyperactivity disorder, autism spectrum disorder and. Location: UNITED STATES , weighting 61.18 lb, Patient experienced the following unwanted or unexpected effects: condition aggravated, tic (What is tic?).

6369973-4 | Confusional State, Disorientation, Disturbance In Attention, Headache, Incoherent, Neurological Examination Abnormal, Vomiting
on Sep 07, 2009 Female patient from UNITED STATES , child 11 years of age, weighting 97.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: confusional state, disorientation, disturbance in attention, headache (What is headache?), incoherent, neurological examination abnormal, vomiting. Daytrana dosage: 1x/day:qd, Transdermal. During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6360620-4 | Electrocardiogram Qt Prolonged, Loss Of Consciousness
on Sep 01, 2009 Female patient from UNITED STATES , child 8 years of age, weighting 61.95 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: electrocardiogram qt prolonged, loss of consciousness. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal.

6305646-1 | Anxiety, Atrial Fibrillation, Insomnia, Off Label Use, Product Quality Issue
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), atrial fibrillation (What is atrial fibrillation?), insomnia, off label use, product quality issue on Jul 30, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 200.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 30 Mg, 1x/day;qd, Transdermal. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), NIASPAN (View Niaspan Review and Niaspan Label ), NEXIUM (View Nexium Review and Nexium Label ), VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

6304095-X | Bone Marrow Failure, Off Label Use
Adverse event was reported on Jul 28, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 15 Mg, 1 X/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 5 years of age, Patient had the following side effects: bone marrow failure, off label use. During the same period patient was treated with METHYLINE TABLET (View Methyline Tablet Review and Methyline Tablet Label ), GUANFACINE (GUANFACINE) TABLET (View Guanfacine (guanfacine) Tablet Review and Guanfacine (guanfacine) Tablet Label ), FOLATE (FOLIC ACID) (View Folate (folic Acid) Review and Folate (folic Acid) Label ), QVAR (BECLOMETASONE DIPROPIONATE) INHALATION GAS (View Qvar (beclometasone Dipropionate) Inhalation Gas Review and Qvar (beclometasone Dipropionate) Inhalation Gas Label ), CYPROHEPTADINE HCL (View Cyproheptadine Hcl Review and Cyproheptadine Hcl Label ).

6300661-6 | Application Site Erythema, Application Site Pain, Application Site Pruritus, Dizziness, Feeling Abnormal, Headache, Lyme Disease, Malaise
on Jul 26, 2009 Male patient from UNITED STATES , child 5 years of age, weighting 41.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site erythema, application site pain, application site pruritus, dizziness (What is dizziness?), feeling abnormal, headache (What is headache?), lyme disease, malaise. Daytrana dosage: 15 Mg, 1x/day: Qd, Transdermal, 20 Mg, 1x/day: Qd, Transdermal. During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ), VITAMINS NOS (VITAMINS NOS) (View Vitamins Nos (vitamins Nos) Review and Vitamins Nos (vitamins Nos) Label ). Patient was hospitalized.

6274615-2 | Condition Aggravated, Homicidal Ideation, Off Label Use
on Jul 08, 2009 Male patient from UNITED STATES , 41 years of age, weighting 170.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, homicidal ideation, off label use. Daytrana dosage: 15 Mg, 1x/day, Qd; Transdermal, 10 Mg, 1x/day; Transdermal. During the same period patient was treated with RUSOERDAL CONSTA (RISPERIDONE) (View Rusoerdal Consta (risperidone) Review and Rusoerdal Consta (risperidone) Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6262706-1 | Intervertebral Disc Protrusion, Off Label Use, Product Quality Issue, Salmonellosis
Patient was taking Daytrana (View Usage). Patient had the following side effects: intervertebral disc protrusion, off label use, product quality issue, salmonellosis on Jul 01, 2009 from UNITED STATES Additional patient health information: Female patient , 44 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal. Patient was hospitalized.

6253574-2 | Autism, Grand Mal Convulsion, Headache, Off Label Use, Petit Mal Epilepsy
Adverse event was reported on Jun 25, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 30 Mg, 1 X/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 13 years of age, weighting 104.9 lb, After Daytrana was administered, patient had the following side effects: autism (What is autism?), grand mal convulsion, headache (What is headache?), off label use, petit mal epilepsy. During the same period patient was treated with FOCALIN (View Focalin Review and Focalin Label ), ALBUTEROL /00139501/ (SALBUTAMOL) (View Albuterol /00139501/ (salbutamol) Review and Albuterol /00139501/ (salbutamol) Label ).

6252888-X | Dehydration, Diarrhoea, Failure To Thrive, Off Label Use, Product Quality Issue, Vomiting
on Jun 18, 2009 Female patient from UNITED STATES , child 4 years of age, weighting 33.07 lb, was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, failure to thrive, off label use, product quality issue, vomiting. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal; 10 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6237761-5 | Abnormal Behaviour, Crying, Disease Recurrence, Kawasaki's Disease, Product Quality Issue
on Jun 12, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 57.10 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: abnormal behaviour, crying, disease recurrence, kawasaki's disease, product quality issue. Daytrana dosage: 15 Mg, 1x/day;qd, Transdermal. During the same period patient was treated with MULTIVITAMIN (ASCORBIC ACID, CALCIUM PANTOTHENATE, ERGOCALCIFEROL, NIC (View Multivitamin (ascorbic Acid, Calcium Pantothenate, Ergocalciferol, Nic Review and Multivitamin (ascorbic Acid, Calcium Pantothenate, Ergocalciferol, Nic Label ), .. (View .. Review and .. Label ).

6229344-8 | Anaphylactic Reaction, Off Label Use
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: anaphylactic reaction, off label use on Feb 24, 2009 from UNITED STATES Additional patient health information: Male patient , child 5 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 15 Mg, 1x/day; Qd, Transdermal. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), RITALIN (View Ritalin Review and Ritalin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ).

6229343-6 | Off Label Use, Product Quality Issue, Respiratory Syncytial Virus Infection
Adverse event was reported on Jan 17, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 10 Mg, 1x/day; Qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 5 years of age, Patient experienced the following unwanted or unexpected effects: off label use, product quality issue, respiratory syncytial virus infection (What is respiratory syncytial virus infection?). During the same period patient was treated with KEPRA (LEVETIRACETAM) (View Kepra (levetiracetam) Review and Kepra (levetiracetam) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6182285-7 | Trichotillomania
on May 05, 2009 Female patient from UNITED STATES , child 11 years of age, weighting 105.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: trichotillomania. Daytrana dosage: 10 Mgs. Over 9 Hours I Patch Daily Transdermal.

6179465-3 | Agitation, Arthralgia, Depression, Somnolence
on May 01, 2009 Male patient from UNITED STATES , 29 years of age, weighting 206.0 lb, was diagnosed with attention deficit/hyperactivity disorder, weight control (What is weight control?) and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: agitation, arthralgia, depression (What is depression?), somnolence. Daytrana dosage: 1 Time A Day. During the same period patient was treated with SOMASLIM PM FORMULA 2 CAPSULES ONCE AT NIGHT GD LABS (View Somaslim Pm Formula 2 Capsules Once At Night Gd Labs Review and Somaslim Pm Formula 2 Capsules Once At Night Gd Labs Label ).

6160358-2 | Blood Bilirubin Increased, Decreased Appetite, Fatigue, Jaundice, Off Label Use, Treatment Noncompliance, Weight Decreased
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, decreased appetite, fatigue, jaundice (What is jaundice?), off label use, treatment noncompliance, weight decreased on Apr 06, 2009 from UNITED STATES Additional patient health information: Female patient , 16 years of age, weighting 140.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 15 Mg, 1x/day; Qd, Transdermal.

6160274-6 | Application Site Reaction, Product Quality Issue, Rash, Skin Disorder
Adverse event was reported on Apr 16, 2009 by a Male patient taking Daytrana (View Usage) (Dosage: 10 Mg/9hr Daily Transdermal Periodic For About 1 Yr) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 7 years of age, weighting 50.00 lb, Patient had the following side effects: application site reaction, product quality issue, rash (What is rash?), skin disorder.

6146749-4 | Application Site Erythema, Burning Sensation, Pain, Pruritus
on Apr 03, 2009 Male patient from UNITED STATES , 20 years of age, weighting 253.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site erythema, burning sensation, pain (What is pain?), pruritus. Daytrana dosage: 30mg Once Daily X9 Hour Transdermal.

6140487-X | Application Site Erythema, Hypersensitivity, Off Label Use
on Mar 24, 2009 Male patient from UNITED STATES , child 5 years of age, weighting 20.50 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, hypersensitivity, off label use. Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal.

6103607-9 | Application Site Bleeding, Application Site Dermatitis, Application Site Erythema, Device Failure, Product Quality Issue, Suicide Attempt
Patient was taking Daytrana (View Usage). Patient had the following side effects: application site bleeding, application site dermatitis, application site erythema, device failure, product quality issue, suicide attempt on Feb 13, 2009 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, weighting 74.96 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ).